BICD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.660800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.193200E-01
Normal-vs-Stage2
9.923000E-01
Normal-vs-Stage3
4.521800E-01
Normal-vs-Stage4
4.652200E-01
Stage1-vs-Stage2
4.165700E-02
Stage1-vs-Stage3
8.695800E-01
Stage1-vs-Stage4
2.580800E-01
Stage2-vs-Stage3
4.039800E-01
Stage2-vs-Stage4
1.188170E-01
Stage3-vs-Stage4
2.286000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.531400E-01
Normal-vs-AfricanAmerican
7.154200E-01
Normal-vs-Asian
6.689800E-01
Caucasian-vs-AfricanAmerican
5.364400E-01
Caucasian-vs-Asian
5.543800E-01
AfricanAmerican-vs-Asian
3.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.888600E-01
Normal-vs-Female
9.330600E-01
Male-vs-Female
8.389200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.722600E-01
Normal-vs-Age(41-60Yrs)
6.407600E-01
Normal-vs-Age(61-80Yrs)
8.280400E-01
Normal-vs-Age(81-100Yrs)
3.024800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.816000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.580400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.697400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.781690E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.849800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.897170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.921400E-01
Normal-vs-Daily Drinker
7.564200E-01
Normal-vs-Weekly Drinker
7.630800E-01
Normal-vs-Occasional Drinker
6.443800E-01
Normal-vs-Social Drinker
9.753000E-01
Non Drinker-vs-Daily Drinker
7.446600E-01
Non Drinker-vs-Weekly Drinker
9.032200E-01
Non Drinker-vs-Occasional Drinker
1.154200E-01
Non Drinker-vs-Social Drinker
5.709000E-01
Daily Drinker-vs-Weekly Drinker
7.080200E-01
Daily Drinker-vs-Occasional Drinker
1.730430E-01
Daily Drinker-vs-Social Drinker
5.611000E-01
Weekly Drinker-vs-Occasional Drinker
2.015400E-01
Weekly Drinker-vs-Social Drinker
7.190600E-01
Occasional Drinker-vs-Social Drinker
3.779800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.382600E-01
Normal-vs-Grade 2
1.073230E-01
Normal-vs-Grade 3
1.766960E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.569900E-02
Grade 1-vs-Grade 3
7.315500E-03
Grade 1-vs-Grade 4
3.382600E-01
Grade 2-vs-Grade 3
1.564250E-01
Grade 2-vs-Grade 4
1.073230E-01
Grade 3-vs-Grade 4
1.766960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.375200E-01
Normal-vs-NonDiabetic
9.546800E-01
Diabetic-vs-NonDiabetic
6.759800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.576200E-01
Normal-vs-NoPancreatitis
9.560800E-01
Pancreatitis-vs-NoPancreatitis
8.886600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.407400E-01
Normal-vs-N1
9.965600E-01
N0-vs-N1
7.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.908800E-01
Normal-vs-TP53-NonMutant
3.379800E-01
TP53-Mutant-vs-TP53-NonMutant
9.537400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
